China Punishes Hospital, Govt Heads For Med Overpricing, Funding Misuse
This article was originally published in PharmAsia News
China's National Audit Office said it had rectified drug overprices of 23 hospitals in 17 counties totaling RMB 66.77 million ($10.73 million), publicized the corrected prices, and punished nine held responsible verbally and administratively.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
Indoco has tripled its operating profit in its financial first quarter ended 30 June 2020. The company has also received FDA approval for its generic version of Eli Lilly’s Zyprexa.
With the Janssen and Novavax deals, the UK has now secured access to six different candidates across four different vaccine types.